Subcutaneous or Transvenous Defibrillator Therapy. Reply

Affiliations

Comment

Reinoud E Knops et al. N Engl J Med. 2021.

. 2021 Feb 18;384(7):678-679.

doi: 10.1056/NEJMc2034917.

¹ Amsterdam University Medical Centers, Amsterdam, the Netherlands r.e.knops@amsterdamumc.nl.

No abstract available

Comment on

Subcutaneous or Transvenous Defibrillator Therapy.
Mandrola J, Enache B, Redberg RF. Mandrola J, et al. N Engl J Med. 2021 Feb 18;384(7):676-677. doi: 10.1056/NEJMc2034917. N Engl J Med. 2021. PMID: 33596366 No abstract available.
Subcutaneous or Transvenous Defibrillator Therapy.
Gallagher MM, Leung LWM, Akhtar Z. Gallagher MM, et al. N Engl J Med. 2021 Feb 18;384(7):677. doi: 10.1056/NEJMc2034917. N Engl J Med. 2021. PMID: 33596367 No abstract available.
Subcutaneous or Transvenous Defibrillator Therapy.
Kim KS, Belley-Côté EP, McIntyre WF. Kim KS, et al. N Engl J Med. 2021 Feb 18;384(7):677-678. doi: 10.1056/NEJMc2034917. N Engl J Med. 2021. PMID: 33596368 No abstract available.
Subcutaneous or Transvenous Defibrillator Therapy.
Sato T, Nojiri A. Sato T, et al. N Engl J Med. 2021 Feb 18;384(7):678. doi: 10.1056/NEJMc2034917. N Engl J Med. 2021. PMID: 33596369 No abstract available.